Nyxoah S.A.
NASDAQ:NYXH
Overview | Financials
Company Name | Nyxoah S.A. |
Symbol | NYXH |
Currency | USD |
Price | 8.01 |
Market Cap | 275,226,804 |
Dividend Yield | 0% |
52-week-range | 4 - 20 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Olivier Taelman |
Website | https://www.nyxoah.com |
An error occurred while fetching data.
About Nyxoah S.A.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD